Edition:
India

People: Sanofi India Ltd (SANO.NS)

SANO.NS on National Stock Exchange of India

6,613.25INR
11 Nov 2019
Change (% chg)

Rs146.35 (+2.26%)
Prev Close
Rs6,466.90
Open
Rs6,454.80
Day's High
Rs6,649.00
Day's Low
Rs6,414.15
Volume
7,130
Avg. Vol
16,205
52-wk High
Rs6,950.00
52-wk Low
Rs5,280.00

Ayyangar, Shailesh 

Dr. Shailesh Ayyangar is re-designated as Non-Executive Director of the Company effective December 31st, 2017. He is currently serves as Managing Director, Executive Director of Sanofi India Limited. He served as the Wholetime Director of Sanofi- Synthelabo (India) Limited. His qualifications are B.V.Fc & A.H., P.G.D.M. IIM (Ahmedabad). Dr. Shailesh Ayyangar assumed office as Managing Director of Aventis Pharma Limited on October 25, 2005. Dr. Ayyangar has wide-ranging experience in the pharmaceutical industry. He held senior Sales and Marketing positions in SmithKline Beecham Pharmaceuticals and GlaxoSmithKline (GSK) in India and Great Britain. He was also Wholetime Director of SmithKline Beecham Pharmaceuticals before its merger with GlaxoWellcome. He was Head of the Tropical Medicine Business unit for International Markets in SmithKline Beecham, UK, for four years prior to his return to India. A graduate in Veterinary Science, Dr. Ayyangar holds a Post-graduate Degree in Business Management from the Indian Institute of Management (IIM), Ahmedabad, Gujarat.

Basic Compensation

Total Annual Compensation, INR 10,755,400
Restricted Stock Award, INR --
Long-Term Incentive Plans, INR --
All Other, INR 736,200
Fiscal Year Total, INR 11,491,600

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --